Delivery Order SPE2DB24D2205-SPE2DB25FEHKT

AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $74,662.13 for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in meeting federal procurement requirements through competitive awards across the Defense Logistics Agency's medical supply chain. Enbrel, a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, represents the type of specialty medication that AmerisourceBergen routinely supplies through its federal contracts. The firm fixed pricing structure and rapid completion timeline reflect the time-sensitive nature of pharmaceutical procurement for military and veteran healthcare systems, which rely on AmerisourceBergen's comprehensive distribution network to maintain critical drug availability across the defense health enterprise.